Streetbeat News

Earnings

IRBT

iRobot shares are trading higher following the announcement of mixed Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:35 pm

CAPL

CrossAmerica Partners (NYSE:CAPL) reported Q4 earnings with an EPS of $0.42, surpassing estimates by 91.0% against an expected $0.22. However, revenue decreased by $109.77 million from the previous year. The company had previously beaten EPS estimates in Q3 2023, which was followed by a stable share price the next day.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 9:35 pm

IRBT

iRobot reported Q4 2023 adjusted EPS of $(1.82), surpassing the $(2.11) estimate, but its sales of $307.54M fell short of the $307.99M estimate, marking a 14.06% year-over-year decline.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:34 pm

DRQ

Dril-Quip projects its FY24 revenue to grow by 15%-20%, with an adjusted EBITDA forecast of $65M-$75M.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:34 pm

HSII

Heidrick & Struggles anticipates its Q1'2024 consolidated net revenue to be between $245M and $265M, surpassing the estimated $242.732M.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:33 pm

TREX

Trex Company, Inc. projects its FY24 net sales to be between $1.215 billion and $1.235 billion, surpassing the estimated $1.22 billion. For Q1, Trex anticipates sales between $360 million and $370 million, significantly higher than the $307.1 million estimate.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:33 pm

STRL

Sterling Infrastructure projects its FY24 adjusted EPS to be between $4.85 and $5.15, surpassing the estimated $4.71. The company also forecasts revenue to range from $2.125 billion to $2.215 billion, slightly below the $2.201 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:32 pm

DHC

Diversified Healthcare (NASDAQ:DHC) reported Q4 2023 earnings of $0.03 per share, missing the consensus estimate of $0.04. However, their quarterly sales of $361.54 million exceeded the estimate of $360.99 million, marking a 7.32% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:32 pm

HIMS

Hims & Hers Health, Inc. (NYSE:HIMS) reported Q4 earnings of 1 cent per share, surpassing the expected loss of 3 cents per share. Quarterly sales reached $246.62 million, beating estimates by 0.33% and marking a 47.5% increase year-over-year. Subscriber count rose to 1.5 million, a 48% increase. The company projects Q1 2024 revenue between $267 million and $272 million, and FY 2024 revenue between $1.17 billion and $1.20 billion, both above estimates. Shares surged 16.1% after-hours to $11.90.

Portfolio Pulse from Erica Kollmann

February 26, 2024 | 9:31 pm

DDS

Dillard's reported a decrease in Q4 earnings per share to $15.44 from $16.89 YoY, with sales slightly down at $2.16B from $2.16B YoY.

Portfolio Pulse from Happy Mohamed

February 26, 2024 | 9:31 pm